Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,367 | 2 | 83.9% |
| Food and Beverage | $455.56 | 26 | 16.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GE HEALTHCARE | $2,397 | 3 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $144.48 | 8 | $0 (2017) |
| Kowa Pharmaceuticals America, Inc. | $141.81 | 9 | $0 (2021) |
| Siemens Medical Solutions USA, Inc. | $40.79 | 2 | $0 (2024) |
| PFIZER INC. | $21.18 | 1 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $17.92 | 1 | $0 (2020) |
| Shire North American Group Inc | $17.56 | 1 | $0 (2017) |
| TriSalus Life Sciences, Inc. | $14.74 | 1 | $0 (2023) |
| Hologic Sales and Service, LLC | $14.20 | 1 | $0 (2024) |
| Merit Medical Systems Inc | $12.22 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.48 | 3 | Siemens Medical Solutions USA, Inc. ($17.06) |
| 2023 | $38.47 | 2 | Siemens Medical Solutions USA, Inc. ($23.73) |
| 2022 | $21.18 | 1 | PFIZER INC. ($21.18) |
| 2021 | $14.21 | 1 | Kowa Pharmaceuticals America, Inc. ($14.21) |
| 2020 | $17.92 | 1 | Janssen Pharmaceuticals, Inc ($17.92) |
| 2019 | $24.70 | 2 | Kowa Pharmaceuticals America, Inc. ($24.70) |
| 2018 | $69.44 | 4 | Kowa Pharmaceuticals America, Inc. ($69.44) |
| 2017 | $2,593 | 14 | GE HEALTHCARE ($2,397) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Siemens Medical Solutions USA, Inc. | NAEOTOM Alpha (Device) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: CT and RO incl. Computed Tomography and Radiation Oncology | ||||||
| 11/07/2024 | Hologic Sales and Service, LLC | 3DIMENSIONS (Device), 3DQUORUM, BREVERA BREAST BIOPSY SYSTEM | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Breast and Skeletal Health | ||||||
| 05/22/2024 | Merit Medical Systems Inc | Corvocet Biopsy System (Device) | Food and Beverage | Cash or cash equivalent | $12.22 | General |
| Category: Radiology | ||||||
| 09/22/2023 | TriSalus Life Sciences, Inc. | TRINAV INFUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: ONCOLOGY | ||||||
| 05/04/2023 | Siemens Medical Solutions USA, Inc. | AI-Rad Companion (Musculoskeletal) (Device) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Digital Health | ||||||
| 06/08/2022 | PFIZER INC. | PREVNAR 20 (Biological), PAXLOVID | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: VACCINES | ||||||
| 04/12/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: Cardiovascular | ||||||
| 08/16/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/27/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.56 | General |
| Category: Cardiovascular | ||||||
| 02/13/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $12.14 | General |
| Category: Cardiovascular | ||||||
| 11/05/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: Cardiovascular | ||||||
| 10/03/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $13.53 | General |
| Category: Cardiovascular | ||||||
| 06/27/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: Cardiovascular | ||||||
| 02/23/2018 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $28.01 | General |
| Category: Cardiovascular | ||||||
| 12/21/2017 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: Cardiovascular | ||||||
| 12/12/2017 | Valeant Pharmaceuticals North America LLC | XIFIXAN (Drug), RELISTOR ORAL, XIFAXANIBSD | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/28/2017 | Valeant Pharmaceuticals North America LLC | RELISTOR ORAL (Drug), XIFAXANIBSD | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | RELISTOR ORAL (Drug), XIFAXANIBSD | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2017 | GE HEALTHCARE | DISCOVERY (Device) | Travel and Lodging | Cash or cash equivalent | $765.75 | General |
| Category: DETECTION & GUIDANCE SOLUTIONS | ||||||
| 07/13/2017 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Vascepa | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: Cardiovascular | ||||||
| 06/20/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug), RELISTOR ORAL, XIFAXANIBSD | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/15/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/08/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug), RELISTOR ORAL, XIFAXANIBSD | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.48 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 163 | 164 | $43,390 | $9,097 |
| 2022 | 5 | 83 | 85 | $13,000 | $3,121 |
| 2021 | 3 | 45 | 45 | $5,480 | $1,286 |
| 2020 | 4 | 71 | 72 | $9,190 | $2,365 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36561 | Insertion of central venous tube with port (5 years or older) | Facility | 2023 | 11 | 11 | $16,610 | $3,016 | 18.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 30 | 30 | $8,700 | $1,925 | 22.1% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 22 | 22 | $5,940 | $1,253 | 21.1% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2023 | 19 | 19 | $5,700 | $1,198 | 21.0% |
| 77012 | Review by radiologist of ct guidance for needle placement | Facility | 2023 | 16 | 16 | $2,880 | $937.76 | 32.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 39 | 40 | $2,000 | $410.67 | 20.5% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Facility | 2023 | 15 | 15 | $900.00 | $224.70 | 25.0% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 11 | 11 | $660.00 | $131.01 | 19.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2022 | 18 | 18 | $4,860 | $1,202 | 24.7% |
| 71275 | Ct scan of blood vessels of chest with contrast | Facility | 2022 | 14 | 14 | $4,200 | $1,009 | 24.0% |
| 71250 | Ct scan of chest without contrast | Facility | 2022 | 12 | 12 | $2,040 | $508.56 | 24.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 24 | 26 | $1,300 | $280.61 | 21.6% |
| 76376 | 3d radiographic procedure | Facility | 2022 | 15 | 15 | $600.00 | $121.20 | 20.2% |
| 36573 | Insertion of central venous catheter for infusion using imaging guidance, patient 5 years or older | Facility | 2021 | 12 | 12 | $3,720 | $874.42 | 23.5% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2021 | 22 | 22 | $1,100 | $234.78 | 21.3% |
| 77001 | Fluoroscopic guidance for insertion, replacement or removal of central venous access device | Facility | 2021 | 11 | 11 | $660.00 | $176.41 | 26.7% |
| 36573 | Insertion of central venous catheter for infusion using imaging guidance, patient 5 years or older | Facility | 2020 | 14 | 15 | $4,650 | $1,121 | 24.1% |
| 77012 | Radiological supervision and interpretation of ct guidance for needle insertion | Facility | 2020 | 12 | 12 | $2,160 | $704.17 | 32.6% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Facility | 2020 | 32 | 32 | $1,600 | $330.31 | 20.6% |
| 77001 | Fluoroscopic guidance for insertion, replacement or removal of central venous access device | Facility | 2020 | 13 | 13 | $780.00 | $209.37 | 26.8% |
About Dr. Gary Cohen, MD
Dr. Gary Cohen, MD is a Vascular & Interventional Radiology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891784559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Cohen, MD has received a total of $2,822 in payments from pharmaceutical and medical device companies, with $43.48 received in 2024. These payments were reported across 28 transactions from 10 companies. The most common payment nature is "Travel and Lodging" ($2,367).
As a Medicare-enrolled provider, Cohen has provided services to 362 Medicare beneficiaries, totaling 366 services with total Medicare billing of $15,868. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Vascular & Interventional Radiology
- Location Philadelphia, PA
- Active Since 10/17/2005
- Last Updated 07/23/2018
- Taxonomy Code 2085R0204X
- Entity Type Individual
- NPI Number 1891784559
Products in Payments
- MR750W 3.0T (Device) $1,632
- DISCOVERY (Device) $765.75
- Livalo (Drug) $141.81
- XIFAXAN (Drug) $67.99
- RELISTOR ORAL (Drug) $44.32
- XIFIXAN (Drug) $32.17
- AI-Rad Companion (Musculoskeletal) (Device) $23.73
- PREVNAR 20 (Biological) $21.18
- XARELTO (Drug) $17.92
- MYDAYIS (Drug) $17.56
- NAEOTOM Alpha (Device) $17.06
- TRINAV INFUSION SYSTEM (Device) $14.74
- 3DIMENSIONS (Device) $14.20
- Corvocet Biopsy System (Device) $12.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Vascular & Interventional Radiology Doctors in Philadelphia
Scott Trerotola, Md, MD
Vascular & Interventional Radiology — Payments: $1.7M
Timothy Clark, Md, MD
Vascular & Interventional Radiology — Payments: $777,227
Andrej Lyshchik, M.d., Ph.d, M.D., PH.D
Vascular & Interventional Radiology — Payments: $593,700
Dr. Abhishek Kumar, M.d, M.D
Vascular & Interventional Radiology — Payments: $281,087
Jason Hoffmann
Vascular & Interventional Radiology — Payments: $193,068
Michael Soulen, Md, MD
Vascular & Interventional Radiology — Payments: $115,695